Publisher
Springer Science and Business Media LLC
Subject
Surgery,Pediatrics, Perinatology and Child Health
Reference27 articles.
1. Bohan A, Stracner JE, Austin MC (2003) A „marathon“ response to infliximab In dermatomyositis. Ann Rheum Dis 62: S502
2. Cheevrel G, Granet C, Miossec P (2005) Contribution of TNF-α and IL1β to IL-6 production, NF-κB nuclear factor translocation and class I MHC expression in muscle cells. In vitro regulation with specific cytokine inhibitors. Ann Rheum Dis 64: 1257–1262
3. Chiappetta N, Steier J, Gruber B (2005) Rituximab in the treatment of refractory dermatomyositis. J Clin Rheumatol 11: 264–266
4. Chung L, Genovese MC, Fiorentino D (2005) Rituximab in the treatment of patients with dermatomyositis: 12 week interim analysis of a pilot trial. Ann Rheum Dis 64: IV55–IV57
5. Efthimiou PV, Schwartzman S, Kagen LJ (2006) Possible role for tumour necrosis factor inhibitors in the treatment of resistant dermatomyositis and polymyositis. A retrospective study in eight patients. Ann Rheum Dis 65: 1233–1236